Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 2
- 主要终点
- Feasibility of Pharmacogenomics testing in a Community pharmacy
研究概览
简要总结
The purpose of this study is to determine the feasibility of pharmacogenomics testing in a community pharmacy using clopidogrel as an example. The investigators hypothesize that this testing is feasible in this setting.
详细描述
To determine if the study is feasible, we will examine the change in patient perception of pharmacogenomics testing (before and after the study), the percentage of patients interested in this service, the response rate of providers to pharmacist recommendations, the pharmacist time requirement, and reimbursement rate for pharmacist services.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Prescribed clopidogrel (Plavix) by their prescriber
- •Aged 18 or older
- •Currently on clopidogrel therapy for one of the following indicated uses: post-ACS, Recent PCI with stenting, History of TIA or stroke
排除标准
- •Are unable to complete study materials (surveys) with or without assistance, including non-English speaking patients
- •Are taking clopidogrel for a reason other than stated in inclusion criteria
- •Are pregnant or nursing
- •Have an allergy to aspirin
结局指标
主要结局
Feasibility of Pharmacogenomics testing in a Community pharmacy
时间窗: 3 months
Change in patient perception of testing, reimbursement for pharmacist time, provider acceptance, and amount of pharmacist time required will be measured as part of the provision of this service.
次要结局
未报告次要终点